220 related articles for article (PubMed ID: 15769185)
1. Gamma-herpesvirus latency requires T cell evasion during episome maintenance.
Bennett NJ; May JS; Stevenson PG
PLoS Biol; 2005 Apr; 3(4):e120. PubMed ID: 15769185
[TBL] [Abstract][Full Text] [Related]
2. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
Fogg MH; Kaur A; Cho YG; Wang F
J Virol; 2005 Oct; 79(20):12681-91. PubMed ID: 16188971
[TBL] [Abstract][Full Text] [Related]
3. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
Gao J; Coulson JM; Whitehouse A; Blake N
J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
[TBL] [Abstract][Full Text] [Related]
4. γ-Herpesvirus reactivation differentially stimulates epitope-specific CD8 T cell responses.
Freeman ML; Burkum CE; Jensen MK; Woodland DL; Blackman MA
J Immunol; 2012 Apr; 188(8):3812-9. PubMed ID: 22407914
[TBL] [Abstract][Full Text] [Related]
5. The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.
Ossevoort M; Zaldumbide A; te Velthuis AJ; Melchers M; Ressing ME; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Jul; 44(14):3588-96. PubMed ID: 17449101
[TBL] [Abstract][Full Text] [Related]
6. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
[TBL] [Abstract][Full Text] [Related]
7. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
Liu L; Usherwood EJ; Blackman MA; Woodland DL
J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
[TBL] [Abstract][Full Text] [Related]
8. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
10. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ
J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222
[TBL] [Abstract][Full Text] [Related]
11. Immune evasion by gamma-herpesviruses.
Stevenson PG
Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
[TBL] [Abstract][Full Text] [Related]
12. Immune evasion by gammaherpesvirus genome maintenance proteins.
Blake N
J Gen Virol; 2010 Apr; 91(Pt 4):829-46. PubMed ID: 20089802
[TBL] [Abstract][Full Text] [Related]
13. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.
Stevenson PG; May JS; Smith XG; Marques S; Adler H; Koszinowski UH; Simas JP; Efstathiou S
Nat Immunol; 2002 Aug; 3(8):733-40. PubMed ID: 12101398
[TBL] [Abstract][Full Text] [Related]
14. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
15. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
16. A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope.
Rice J; de Lima B; Stevenson FK; Stevenson PG
Eur J Immunol; 2002 Dec; 32(12):3481-7. PubMed ID: 12442330
[TBL] [Abstract][Full Text] [Related]
17. Macavirus latency-associated protein evades immune detection through regulation of protein synthesis in cis depending upon its glycin/glutamate-rich domain.
Sorel O; Chen T; Myster F; Javaux J; Vanderplasschen A; Dewals BG
PLoS Pathog; 2017 Oct; 13(10):e1006691. PubMed ID: 29059246
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
Stevenson PG; Efstathiou S; Doherty PC; Lehner PJ
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8455-60. PubMed ID: 10890918
[TBL] [Abstract][Full Text] [Related]
19. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.
Murray RJ; Kurilla MG; Brooks JM; Thomas WA; Rowe M; Kieff E; Rickinson AB
J Exp Med; 1992 Jul; 176(1):157-68. PubMed ID: 1319456
[TBL] [Abstract][Full Text] [Related]
20. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
